2011-12-24 by MANISHA BISWAS
WASHINGTON, Dec. 24 -- The U.S. Army Medical Research Acquisition Activity has announced that it expects to award a discretionary cooperative agreement grant for supporting antimalarial research in Cambodia.
The estimated total program funding available was cited as $2.2 million.
This funding opportunity is open to any entity, such as state, county, city, township and special district governments; Native American tribal governments and organizations; institutions of higher education; Historically Black Colleges and Universities; Tribally-Controlled Colleges and Universities; non-profits; for-profits; small businesses; eligible agencies of the federal government; and faith-based or community organizations.
A funding opportunity notice from NIH states: "This Program Announcement/Funding Opportunity, WRAIR Malaria Prevention Research Award (MTRLP-MPRA) is soliciting proposals for clinical research to support antimalarial research in Cambodia. Research will be focused on development of new products to include drugs and vaccines, improved use of existing antimalarial drugs, and active epidemiologic surveillance for drug resistance. The research will take place at AFRIMS established clinical research sites and/or facilities within Cambodia, or at new sites approved by the Cambodian Ministry of Health and/or other appropriate authorities."
The funding opportunity number is W81XWH-12-WRAIR-MTRLP-MPRA (CDFA 12.420). The application closing date is Jan. 31.
For more information, contact Wanda Harper, 301/619-8094. NewsFocusCode FedGrants NWNAgrants federalgrants TNSFG111223
No comments:
Post a Comment